Strides Arcolab’s injectable drug division forms JV with Jamp Pharma

11 Jul 2012 Evaluate

Agila Specialties Pharma Corporation, Canada, which is part of the injectable drug division of Strides Arcolab, a globally renowned generic drug manufacturer, has formed a joint venture (JV) with Jamp Pharma, a Canadian generic drug company, to introduce a variety of quality injectable generic drug in Canada.

This sales and marketing joint venture will operate under the name Agila-jamp Canada Inc in which Agila will hold 70% stake and the remaining 30% by Jamp Pharma. The JV will be headquartered in Boucherville, Quebec.

Agila-jamp will be launching around 40 products in the next 2 years. Many of these products have already been approved by Health Canada and will be immediately launched through local hospital and pharmacists. The existing sales force at Jamp Pharma will be responsible to introduce the entire Agila-Jamp product portfolio.

Strides Arcolab is a global pharmaceuticals headquartered in Bangalore, India that develops and manufactures a wide range of IP-led niche pharmaceuticals products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

873.65 -5.00 (-0.57%)
08-Dec-2025 09:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1796.25
Dr. Reddys Lab 1274.40
Cipla 1512.50
Zydus Lifesciences 934.40
Lupin 2094.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×